PTX 3 (pentraxin3) 与稳定阶段吸烟相关的慢性阻塞性肺病患者的肺功能有关
Xincheng Liu1, Rui Li2, Maoxu Xia1
1Department of Respiratory and Critical Care Medicine, Mingguang People's Hospital, no.379 Mingguang Avenue, Mingguang City, Chuzhou City, 239400 Anhui Province, PR China.
Heart & lung : the journal of critical care
|December 22, 2024
概括
血Pentraxin-3 (PTX3) 水平可以帮助预测稳定慢性阻塞性肺病 (COPD) 患者的恶化. 增加的PTX3与吸烟者的疾病严重程度和肺功能下降有关.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 生物标志物研究 生物标志物研究
- 临床诊断 临床诊断 临床诊断
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种广泛的呼吸系统疾病.
- 在COPD恶化期间观察到升高的Pentraxin-3 (PTX3),但其诊断作用尚不清楚.
研究的目的:
- 为了研究血PTX3在COPD中的功能作用.
- 评估PTX3与肺功能和疾病严重程度的关系.
主要方法:
- 预计将招募170名稳定的COPD患者和健康对照组.
- 根据吸烟史进行分类.
- 分析肺功能,临床分数和血PTX3水平.
主要成果:
- 与吸烟相关的COPD患者显示FEV1/FVC降低,PTX3,mMRC和CAT得分升高.
- PTX3与mMRC/CAT得分正相关,与FEV1.1负相关.
- 增加的PTX3,吸烟指数和NLR是恶化的独立风险因素.
结论:
- 血PTX3水平> 246.2 ng/mL可能预测稳定,吸烟相关的COPD的恶化.
- PTX3显示出作为COPD管理的有价值的临床指标的潜力.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:47Lung Capacity
49.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
49.3K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:27Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K